Stock Events

Stock Events

Talphera 

$1.1900
66
-$0.02-1.65% 16:30 Today

Statistics

Day High
1.23
Day Low
1.18
52W High
1.57
52W Low
0.42
Volume
360,768
Avg. Volume
318,151
Mkt Cap
61.77M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.19
-0.14
-0.09
-0.04
Expected EPS
-0.05
Actual EPS
N/A

Financials

-51,035.71%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
28,000Revenue
-14.29MNet Income

Analyst Ratings

3.00Average Price Target
The highest estimate is 3.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TLPH. It's not an investment recommendation.
Rocket Lab
5
RKLB
Microsoft
4
MSFT
Tesla
4
TSLA
Amazon
4
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap335.14B
Merck & Co., Inc. is a leading global biopharmaceutical company that competes with Talphera in the development and marketing of prescription medicines, vaccines, biologic therapies, and animal health products.
Pfizer
PFE
Mkt Cap152.69B
Pfizer Inc. is a global pharmaceutical corporation which competes directly with Talphera in various therapeutic areas, including oncology, rare diseases, and immunology.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Talphera in the discovery, development, and delivery of innovative medicines that help patients prevail over serious diseases.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need, competing with Talphera in the fields of antiviral drugs, cancer, and other diseases.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie Inc. is a research-based biopharmaceutical company that develops and markets advanced therapies, competing with Talphera in areas such as immunology and oncology.
AMGEN
AMGN
Mkt Cap224.63B
Amgen Inc. is one of the world's leading biotechnology companies, competing with Talphera in developing innovative human therapeutics, including treatments for serious illnesses.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson is a comprehensive healthcare company that competes with Talphera through its pharmaceutical segment, developing drugs for a wide range of medical conditions.
Novartis
NVS
Mkt Cap286.78B
Novartis AG is a global healthcare company based in Switzerland that competes with Talphera in researching, developing, manufacturing, and marketing a broad range of healthcare products.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Roche competes with Talphera in the pharmaceutical sector, particularly in oncology and virology.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biopharmaceutical company that competes with Talphera in developing and commercializing prescription medicines for several therapeutic areas, including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

About

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Show more...
CEO
Vincent J. Angotti
Employees
12
Country
United States
ISIN
US00444T2096
WKN
000A3DWPN

Listings

MU
DE
R5X.MU
F
DE
R5XA.F
STU
DE
R5XA.STU
XNAS
US
TLPH

0 Comments

Share your thoughts

FAQ

What is Talphera stock price today?▼
The current price of TLPH is $1.19 USD — it has decreased by -1.65% in the past 24 hours. Watch Talphera stock price performance more closely on the chart.
What is Talphera stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Talphera stocks are traded under the ticker TLPH.
Is Talphera stock price growing?▼
TLPH stock has fallen by -14.34% compared to the previous week, the month change is a -9.81% fall, over the last year Talphera has showed a +166.74% increase.
What is Talphera market cap?▼
Today Talphera has the market capitalization of 61.77M
When is the next Talphera earnings date?▼
Talphera is going to release the next earnings report on November 16, 2026.
What were Talphera earnings last quarter?▼
TLPH earnings for the last quarter are -0.06 USD per share, whereas the estimation was -0.06 USD resulting in a +4% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Talphera revenue for the last year?▼
Talphera revenue for the last year amounts to 28,000 USD.
What is Talphera net income for the last year?▼
TLPH net income for the last year is -14.29M USD.
How many employees does Talphera have?▼
As of August 19, 2026, the company has 12 employees.
In which sector is Talphera located?▼
Talphera operates in the Health & Wellness sector.
When did Talphera complete a stock split?▼
The last stock split for Talphera was on October 26, 2022 with a ratio of 1:20.
Where is Talphera headquartered?▼
Talphera is headquartered in SAN MATEO, United States.